Twenty-seven consecutive patients with advanced gynecologic malignancies undergoing chemotherapy with cisplatin in combination with other agents were studied in a prospective, randomized fashion to compare the antiemetic efficacy of a combination regimen with high-dose metoclopramide. The combination regimen consisted of prochlorperazine, dexamethasone, and pentobarbital. Patients treated with the combination regimen had significantly less vomitus (P less than 0.01, Student's t test) and fewer vomiting episodes (P less than 0.001, test for homogeneity) than patients treated with metoclopramide. In addition, the sedative and sleep-inducing effect of the barbiturate made the experience of vomiting more tolerable, even in those instances where the combination regimen was not superior to metoclopramide in the control of vomiting.

Download full-text PDF

Source
http://dx.doi.org/10.1002/1097-0142(19850601)55:11<2645::aid-cncr2820551119>3.0.co;2-jDOI Listing

Publication Analysis

Top Keywords

combination regimen
16
patients treated
8
combination
6
combination antiemetic
4
antiemetic therapy
4
therapy cisplatin-induced
4
cisplatin-induced nausea
4
vomiting
4
nausea vomiting
4
vomiting twenty-seven
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!